Preliminary results of a Cancer Research UK phase I trial combining the dinitrobenzamide prodrug CB1954 (tretazicar) and the NQO2 substrate EP-0152R (caricotamide)

Bibliographic Details
Main Authors:	Sarker, D, Anderson, D, Spanswick, V, Davies, S, Agarwal, R, Aitken, G, Kerr, D, Hartley, J, Judson, I, Middleton, MR
Format:	Journal article
Published:	2008

Similar Items